Cough syrup banned

Hyderabad: Experts have issued a warning advising against the consumption of certain According to Section 26A of the Drugs and Cosmetic Act, 1940 (23 of 1940), the manufacture, sale, and distribution of the fixed dose combination of Nimesulide plus Paracetamol dispersible tablets for human use has been prohibited, as stated in notification number SO 712 (E) issued on March 10, 2016. In response to this, the central government formed an expert committee on April 1, 2022, to submit a report regarding this drug to the central government and Drug Technical Advisory Board. Based on the committee’s report, the central government issued a notification on June 2, banning these drugs. The expert committee recommended that “there is no therapeutic justification for this fixed dose combination, and it may pose risks to human beings. Therefore, in the best interest of the public, it is necessary to prohibit the manufacture, sale, or distribution of this combination under Section 26A of the Drugs and Cosmetics Act, 1940. Considering this, any form of regulation or restriction to allow its use in patients is not justified. Hence, only prohibition under Section 26A is recommended.” Akula Sanjay Reddy, a member of the Telangana Pharma Council, stated that the government has banned several drugs used for treating coughs, colds, and respiratory infections, citing a lack of therapeutic rationale. He mentioned that there are at least ten such combinations that violate the regulations, includi...

Authors • Nial Wheate Associate Professor of the Sydney Pharmacy School, University of Sydney • Tina Hinton Associate Professor of Pharmacology, University of Sydney Disclosure statement Associate Professor Wheate in the past has received funding from the ACT Cancer Council, Tenovus Scotland, Medical Research Scotland, Scottish Crucible, and the Scottish Universities Life Sciences Alliance. He is a Fellow of the Royal Australian Chemical Institute, a member of the Australasian Pharmaceutical Science Association, and a member of the Australian Institute of Company Directors. Nial is the chief scientific officer of Vairea Skincare LLC, a director of SetDose Pty Ltd a medical device company, and a Standards Australia panel member for sunscreen agents. Associate Professor Tina Hinton has previously received funding from the Schizophrenia Research Institute (formerly Neuroscience Institute of Schizophrenia and Allied Disorders). She is currently a Board member of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists. Partners The Conversation UK receives funding from these organisations View the full list Cough medicines containing the active ingredient pholcodine are being withdrawn from sale due to safety concerns highlighted for years both in Australia and internationally. Yesterday, Australia’s medicines regulator This is because of the risk of a sudden, severe and life-threatening allergic reaction if people are also given specific muscle ...

Tennessee and New Jersey are the latest states to enact legislation prohibiting sales of over-the-counter (OTC) cough medicines containing dextromethorphan (DXM) to minors. The laws are designed to decrease the abuse rate of these medicines by teens, while maintaining access for legitimate consumers of these products. Tennessee’s law took effect January 1, 2016, while New Jersey’s law took effect February 1. California was the first state to prohibit sales to minors in 2012. The “The laws not only prevent young teens from abusing these products, but by requiring proof of age, they make parents aware of the problem,” Roberson said. She spoke about preventing cough medicine abuse recently at the Community Anti-Drug Coalitions of America (CADCA) 26th National Leadership Forum in Washington, D.C. An estimated DXM is the active ingredient in most OTC cough medicines. According to the CHPA, it is safe and effective when taken according to labeling instructions. However, when taken in excessive amounts higher than recommended doses, DXM can product side effects including nausea and vomiting; stomach pain; confusion; dizziness; double or blurred vision; slurred speech; impaired physical coordination; rapid heartbeat; drowsiness; numbness of fingers and toes; and disorientation. In addition, many medicines containing DXM may also contain other ingredients such as antihistamines, analgesics or decongestants. High doses of these combination medicines can greatly increase the harmful ...

• • • • The World Health Organization is investigating a possible connection between contaminated cough syrups and the over 300 children who died after using the spoiled medication last year. The investigation hopes to see whether the raw materials used to produce cough syrup by six manufacturers in India and Indonesia contained “unacceptable levels” of toxins — and as a result, caused the spate of deaths, someone with knowledge of the matter WHO is also looking to see whether the manufacturers received the bad materials from some of the same suppliers. The agency has not named any of the suppliers it is investigating. It is also considering warning families across the globe against using cough syrup to treat children while it remains unclear whether the products are safe. Experts are also researching whether products like cough syrup are medically necessary for children, the person told Reuters. Within the past year, more than 300 children died of acute kidney injury in deaths that were associated with contaminated medicines, the WHO said in a statement Monday. Most of those children were under the age of 5 and lived in Gambia, Indonesia and Uzbekistan. Their deaths were linked to medications that were found to contain high levels of toxic diethylene glycol and ethylene glycol. The World Health Organization is investigating a potential connection between contaminated cough syrups and the deaths of 300 children across several countries. Photo by MILAN BERCKMANS/AFP via Get...